Effect of ceruletide on pituitary-hypothalamic peptides and on emotion in man.
In order to clarify the mechanism of the analgesic effect of ceruletide (CRL), the peptides B-endorphin (BE), ACTH, prolactin (PRL), growth hormone (GH) and substance P were determined in the basal state and following IV CRL administration in 11 patients. CRL, at the dose of 2 ng/kg/min, significantly augmented BE levels in the plasma, and in CSF. Substance P levels were significantly augmented by CRL in the plasma, while ACTH levels were significantly augmented in CSF. GH and PRL levels were not affected by CRL. Placebo had no effect on any of the measured peptides. The effect of CRL on mood and anxiety, known to be affected by opioids, was studied in 14 patients with psychogenic headache. The effect of histamine induced headache on State trait anxiety inventory and on Mood adjective check list was studied before and after administration of placebo or CRL. CRL significantly diminished anxiety when compared to placebo. Elation, surgency and egotism were significantly augmented while skepticism was significantly diminished by CRL. The CRL effect on mood and pain may be mediated by augmented levels of neurohormones both in the plasma and in CSF.
D000324:Adrenocorticotropic Hormone / Q000134:cerebrospinal fluid*; D000328:Adult; D000698:Analgesia; D001007:Anxiety; D002108:Ceruletide / Q000494:pharmacology*; D004644:Emotions / Q000187:drug effects*; D004723:Endorphins / Q000097:blood* / Q000134:cerebrospinal fluid; D013006:Growth Hormone / Q000378:metabolism; D006632:Histamine; D006801:Humans; D008297:Male; D011388:Prolactin / Q000378:metabolism; D013373:Substance P / Q000097:blood*; D001615:beta-Endorphin
D004723:Endorphins; D013373:Substance P; D001615:beta-Endorphin; D006632:Histamine; D002108:Ceruletide; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013006:Growth Hormone